Compare
Peptide Comparisons
Neutral, side-by-side comparisons of peptide compounds by drug class, regulatory status, evidence grade, and tracked clinical trials. No efficacy claims or recommendations.
- BPC-157 vs TB-500Synthetic stable gastric pentadecapeptide (15-amino-acid partial sequence derived from a protein in human gastric juice) · Synthetic peptide fragment (Ac-LKKTETQ) corresponding to the actin-binding region of thymosin beta-4; note it is NOT the same molecule as full-length recombinant thymosin beta-4
- CJC-1295 vs IpamorelinGrowth hormone-releasing hormone (GHRH) analog · Growth hormone secretagogue; ghrelin (GHS-R1a) receptor agonist (pentapeptide)
- Liraglutide vs SemaglutideGlucagon-like peptide-1 (GLP-1) receptor agonist (acylated GLP-1 analogue) · Glucagon-like peptide-1 (GLP-1) receptor agonist
- Retatrutide vs SemaglutideTriple agonist of the GIP, GLP-1, and glucagon receptors (investigational incretin/metabolic peptide) · Glucagon-like peptide-1 (GLP-1) receptor agonist
- Retatrutide vs TirzepatideTriple agonist of the GIP, GLP-1, and glucagon receptors (investigational incretin/metabolic peptide) · Dual agonist of the GIP and GLP-1 receptors (incretin-based metabolic peptide)
- Semaglutide vs TirzepatideGlucagon-like peptide-1 (GLP-1) receptor agonist · Dual agonist of the GIP and GLP-1 receptors (incretin-based metabolic peptide)